- 5Y
- +570.33%
- $10K became
- $67,033
AVGO vs QCOM
Total return with dividends reinvested · 5Y
- 5Y
- +14.21%
- $10K became
- $11,421
Return and risk 5Y
| Ticker | $10K became | Total | Per year | Volatility | Worst drop | Off high now | Best year | Worst year | Years up | Corr. with AVGO |
|---|---|---|---|---|---|---|---|---|---|---|
| AVGO | $67,033 | +570.33% | +46.37% | 45.3% | -41.15% | -27.69% | +116.42% 2024 | -12.97% 2022 | 75% | — |
| QCOM | $11,421 | +14.21% | +2.70% | 43.1% | -44.26% | -30.65% | +38.54% 2023 | -39.68% 2022 | 75% | 0.54 |
- $10K became
- $67,033
- Total
- +570.33%
- Per year
- +46.37%
- Volatility
- 45.3%
- Worst drop
- -41.15%
- Off high now
- -27.69%
- Best year
- +116.42% 2024
- Worst year
- -12.97% 2022
- $10K became
- $11,421
- Total
- +14.21%
- Per year
- +2.70%
- Volatility
- 43.1%
- Worst drop
- -44.26%
- Off high now
- -30.65%
- Best year
- +38.54% 2023
- Worst year
- -39.68% 2022
Per year: compound annual growth rate, needs a year of history. Volatility: yearly spread of daily returns. Best and worst years: full calendar years only.
Drawdown from peak 5Y
Correlation of daily returns
1 moves together, 0 unrelated, negative moves opposite. Lower means more diversification.
Trailing returns up to 5 years
| Ticker | 1Y | 2Y | 3Y | 5Y |
|---|---|---|---|---|
| AVGO | — | — | — | — |
| QCOM | — | — | — | — |
Calendar-year returns best each year in bold
| Year | AVGO | QCOM |
|---|---|---|
| No full years in this range yet. | ||
More comparisons
About this comparison
Summary, desk note and 6 common questions.
Broadcom Inc. (AVGO) vs QUALCOMM Incorporated (QCOM) total return over 5Y: AVGO +570.33%, QCOM +14.21%. Regime AVGO RECOVERY. As of Nov 13, 2026. Research only.
As of 2026-10-23, Broadcom (AVGO) closed at $321.7, while Qualcomm (QCOM) traded at $175.9. Both semiconductors currently carry a SELL directional signal, reflecting a broader bearish market regime. However, their fundamental profiles diverge sharply. AVGO exhibits high-growth characteristics with a P/E of 39.91 and 48.69% revenue growth, driven by AI infrastructure demand. In contrast, QCOM presents a value-oriented profile with a 20.04 P/E, 2.06% dividend yield, and 4.92% buyback yield, though it faces headwinds from negative EPS growth. The total-return overlay highlights this distinction over the past five years. AVGO delivered a +573.4% return, significantly outpacing QCOM’s +48.8% performance. This gap underscores the market’s premium on AVGO’s AI-driven expansion versus QCOM’s more stable, but slower, wireless licensing model. Investors analyzing these tickers should note that AVGO’s growth trajectory has historically compensated for its higher valuation multiples, whereas QCOM’s returns have been bolstered by consistent capital returns to shareholders.
What does the AVGO vs QCOM overlay show?
LOPJLB overlays AVGO vs QCOM as total return (dividends and splits) from the first adjusted close in the selected 5Y window. Each path starts at 0% so you can read relative holding performance, not raw tape price.
Is this holding return or tape close?
Holding return. The series uses split- and dividend-adjusted close (Yahoo-style backward adjustment) when dividend coverage is sufficient, otherwise it falls back to tape close. Candles and technical overlays on /chart stay tape.
Which windows are public?
Public visitors can share 1M, 3M, 6M, YTD, 1Y, and 5Y. MAX is Research+. Direction and regime in the table follow the desk ladder: SPY25 on Free, full book on Essential+.
How do I read the drawdown, period, and annual tables?
Drawdowns are current and worst peak-to-trough on the visible range. Periods are calendar lookbacks (1Y / 2Y / 3Y / 5Y, plus 10Y on MAX) from the last bar. Annual is calendar-year holding return, with the latest year labeled YTD.
How has AVGO vs QCOM performed on a normalized basis?
AVGO vs QCOM holding-return overlay: 5Y AVGO +570.33% · QCOM +14.21%; worst drawdown AVGO -41.15% · QCOM -44.26%; YTD AVGO +0.37% · QCOM +1.29%. Numbers update from the live compare-series book.
Is ticker compare investment advice?
No. The overlay is research context only — not a recommendation to buy or sell any security.